Cure My Disease

Don't miss your cure!

 Log in / Sign up

New scan may reveal hidden clues to lung cancer treatment success

NCT ID NCT06833229

Recruiting now Knowledge-focused Sponsor: Centre Antoine Lacassagne Source: ClinicalTrials.gov ↗

First seen Jun 02, 2026 · Last updated Jun 13, 2026 · Updated 2 times

Summary

This study looks at whether a special PET scan can tell early on if immunotherapy (with or without chemo) is working for advanced lung cancer. It aims to tell the difference between true tumor growth and harmless inflammation that can look like growth. About 200 adults with non-small cell lung cancer will get a PET scan 6 weeks into treatment to see if the scan can predict the outcome.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG (NSCLC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Antoine Lacassagne

    RECRUITING

    Nice, 06189, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CARCINOMA, NON-SMALL-CELL LUNG (NSCLC)

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.

NON-SMALL CELL LUNG CANCER